Current Status of Robotic Gastrointestinal Surgery.

Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
PMID:

Abstract

Development of surgical support robots began in the 1980s as a navigation and auxiliary device for endoscopic surgery. For remote surgery on the battlefield, a master-slave-type surgical support robot was developed, in which a console surgeon operates the robot at will. The da Vinci surgical system, which currently dominates the global robotic surgery market, received United States Food and Drug Administration and regulatory approval in Japan in 2000 and 2009 respectively. The latest, fourth generation, da Vinci Xi has a good field of view via a three-dimensional monitor, highly operable forceps, a motion scale function, and a tremor-filtered articulated function. Gastroenterological tract robotic surgery is safe and minimally invasive when accessing and operating on the esophagus, stomach, colon, and rectum. The learning curve is said to be short, and robotic surgery will likely be standardized soon. Therefore, robotic surgery training should be systematized for young surgeons so that it can be further standardized and later adapted to a wider range of surgeries. This article reviews current trends and potential developments in robotic surgery.

Authors

  • Keisuke Minamimura
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Keisuke Hara
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Satoshi Matsumoto
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Tomohiko Yasuda
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Hiroki Arai
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Daisuke Kakinuma
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Yukio Ohshiro
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Youichi Kawano
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Masanori Watanabe
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Hideyuki Suzuki
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital.
  • Hiroshi Yoshida
    Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. hiroyosh@ncc.go.jp.